Cash Flow Statement

Altimmune (ALT) Return on Sales Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 5.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.00
10 Altimmune 379.61 Mn 379.61 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 262.00
Sep 30, 2025 7,955.00
Jun 30, 2025 -1,913.00
Mar 31, 2025 -3,304.00
Dec 31, 2024 -4,634.00
Sep 30, 2024 -4,357.00
Jun 30, 2024 -4,747.00
Mar 31, 2024 -4,861.00
Dec 31, 2023 -236.00
Sep 30, 2023 -51.00
Jun 30, 2023 -2,692.00
Mar 31, 2023 -955.00
Dec 31, 2022 1,972.00
Sep 30, 2022 -11,741.00
Jun 30, 2022 -2,514.00
Mar 31, 2022 -610.00
Dec 31, 2021 10.00
Sep 30, 2021 -211.00
Jun 30, 2021 -177.00
Mar 31, 2021 -17.00
Dec 31, 2020 0.00
Sep 30, 2020 0.00
Jun 30, 2020 -3.00
Mar 31, 2020 10.00
Dec 31, 2019 -4.00
Sep 30, 2019 957.00
Jun 30, 2019 1.00
Mar 31, 2019 1.00
Dec 31, 2018 -11.00
Sep 30, 2018 0.00
Jun 30, 2018 -2.00
Mar 31, 2018 -1.00
Dec 31, 2017 -4.00
Sep 30, 2017 -2.00
Jun 30, 2017 -1.00
Mar 31, 2017 -11.00
Dec 31, 2016 -1.00
Sep 30, 2016 -973.00
Jun 30, 2016 -2.00
Mar 31, 2016 -1.00
Dec 31, 2015 -1.00
Sep 30, 2015 -1.00
Jun 30, 2015 -2.00
Mar 31, 2015 1.00
Dec 31, 2014 -2.00
Sep 30, 2014 -5.00
Jun 30, 2014 0.00
Mar 31, 2014 0.00
Dec 31, 2013 0.00
Sep 30, 2013 0.00
Jun 30, 2013 1.00